Records containing: Recurrent Glioblastoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-02-17A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
-
CLINICAL_TRIALS study record update · 2020-01-09A Phase 2 Study of Orally Administered PLX3397 in Patients With Recurrent Glioblastoma
-
CLINICAL_TRIALS study record update · 2020-01-02Phase I Trial of a Measles Virus Derivative Producing CEA (MV-CEA) in Patients With Recurrent Glioblastoma Multiforme (GBM)
-
CLINICAL_TRIALS study record update · 2019-07-02Phase II Clinical Trials on Anlotinib for the Treatment of Recurrent Glioblastoma.
-
CLINICAL_TRIALS study record update · 2019-06-12A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-07-19Phase I Clinical Trial of Nasal Spray in Treating Patients With Recurrent Glioblastoma, Gliosarcoma, Glioma
-
CLINICAL_TRIALS study record update · 2017-02-27Phase II Double-Blinded Placebo-Controlled Study of Bevacizumab With or Without AMG 386 in Patients With Recurrent Glioblastoma or Gliosarcoma
-
CLINICAL_TRIALS study record update · 2016-09-23Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
-
CLINICAL_TRIALS study record update · 2016-03-16A Randomized Phase III Study of Re-Irradiation in Recurrent Glioblastoma
-
CLINICAL_TRIALS study record update · 2013-12-13Ketogenic Diet for Patients With Recurrent Glioblastoma
-
CLINICAL_TRIALS study record update · 2013-06-19Phase II Study of Panobinostat (LBH589) for Recurrent Glioblastoma (GBM) Undergoing Planned Surgical Resection
-
CLINICAL_TRIALS study record update · 2012-12-21A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
-
CLINICAL_TRIALS study record update · 2012-10-04Phase II Study of BIBF 1120 in Recurrent Glioblastoma Multiforme
-
CLINICAL_TRIALS study record update · 2009-11-25A Phase I, Open Label, Multi-Centre Study to Assess the Safety and Tolerability of Cediranib (RECENTIN™, AZD2171) in Combination With Lomustine Chemotherapy for Patients With Primary Recurrent Malignant Brain Tumours for Whom Lomustine Would be a Standard Therapy
-
CLINICAL_TRIALS study record update · 2007-10-23A Phase II Open Label Study of the Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research